Core Viewpoint - The article discusses the potential risks and implications of the brand expansion strategy employed by Beijing Tongrentang, a well-known traditional Chinese medicine brand, highlighting issues related to product quality and brand integrity due to extensive licensing and outsourcing practices [1][3][10]. Group 1: Brand Integrity and Quality Issues - Beijing Tongrentang issued an apology regarding a product quality issue with its "99% high-purity Antarctic krill oil," which claimed a phospholipid content of 43% but was found to be 0% in actual tests [3][10]. - The brand's licensing model has led to a proliferation of products under the Tongrentang name, many of which are produced by third-party manufacturers, raising concerns about the authenticity and quality of these products [3][4][10]. - The complexity of brand ownership and licensing has resulted in confusion among consumers, as multiple entities within the Tongrentang group produce and sell products under similar names, leading to difficulties in distinguishing genuine products from counterfeit ones [6][7][10]. Group 2: Business Model and Market Strategy - The company has expanded its product offerings significantly, including health supplements and daily necessities, which has been referred to as the "Tongrentang Universe," but this expansion raises questions about brand dilution [3][4][10]. - Beijing Tongrentang Health Pharmaceutical has adopted a direct sales model for its health products, which is often associated with negative perceptions in the market, potentially risking the brand's reputation [10][12]. - The company is facing financial challenges, with a reported net profit of 1.526 billion yuan for 2024, marking an 8.54% decline year-on-year, indicating a need for strategic reevaluation amidst its aggressive expansion efforts [12]. Group 3: Consumer Trust and Brand Management - The article emphasizes the importance of establishing modern corporate governance and a robust authorization system to restore consumer trust in the Tongrentang brand, which has been built over a century [12]. - The dual approach of maintaining traditional practices while attempting to attract younger consumers through innovative strategies reflects the internal contradictions faced by the brand during its rapid expansion [12].

Group 1 - The core activity is a series of public welfare events initiated by Tongrentang Technology Company and Beijing Youth Daily, focusing on integrating traditional Chinese medicine (TCM) culture into rural revitalization efforts [1][21] - The events include winter health consultations and TCM cultural experience activities, aimed at promoting health and wellness through TCM knowledge [1][10] - The activities are designed to be engaging and educational, featuring hands-on experiences such as making traditional Chinese medicine pills and learning about herbal identification [3][5] Group 2 - In the community, TCM lectures cover winter health tips, dietary recommendations, and acupoint massage techniques, helping residents understand TCM practices [12][14] - The events also include interactive experiences, such as creating aromatic bracelets, which enhance community engagement with TCM culture [15] - Health consultations provided by experts from Tongrentang and Beijing University of Chinese Medicine address residents' health concerns, offering personalized advice and treatments [17][19] Group 3 - A separate initiative focuses on children with autism, providing TCM cultural experiences and health consultations tailored to their needs [21][23] - The program includes donations of essential rehabilitation materials and aims to improve the well-being of special needs children through TCM therapies [21][23] - The immersive activities allow participants to experience TCM culture through multiple senses, fostering a deeper appreciation for its benefits [23]

Core Viewpoint - The "Golden Award" annual excellence company selection by Gelonghui highlights companies that excel in both economic performance and social responsibility, particularly focusing on ESG (Environmental, Social, Governance) criteria [1][2]. Group 1: Award Winners - Eight companies received the "Annual ESG Pioneer Award (Small and Medium Market Capitalization)" for their outstanding contributions to promoting ESG principles and sustainable development: - Li Jin Technology (00558.HK) - Lianyi Rong Technology-W (09959.HK) - Mobi Development (00947.HK) - Qingci Games (06633.HK) - Tianlun Gas (01600.HK) - Tongrentang Technology (01666.HK) - Weimob Group (02013.HK) - Zhonghui Group (00382.HK) The ranking is in alphabetical order and does not imply any hierarchy [1]. Group 2: Evaluation Criteria - The selection process for the awards involved quantitative data analysis and evaluation by an expert panel, ensuring a comprehensive assessment of the companies' ESG efforts [1]. - The "Annual ESG Pioneer Award" aims to recognize companies that balance economic efficiency with social responsibility, emphasizing their commitment to high-quality sustainable development [1]. Group 3: Event Overview - Gelonghui hosted an online sharing session titled "Technology Empowerment, Capital Breakthrough" on December 22, where the award winners were announced [1]. - The "Golden Award" aims to create a valuable reference list of listed companies and unicorns, covering all listed companies on major exchanges including the Hong Kong Stock Exchange, Shanghai Stock Exchange, Shenzhen Stock Exchange, New York Stock Exchange, and NASDAQ [2].

Core Viewpoint - The "Annual ESG Pioneer Award (Small and Medium Market Capitalization)" recognizes companies that balance economic efficiency with social responsibility, highlighting their contributions to environmental, social, and governance (ESG) practices [1][2]. Group 1: Award Recipients - Eight companies received the "Annual ESG Pioneer Award (Small and Medium Market Capitalization)": - Li Jin Technology (00558.HK) - Lianyi Rong Technology-W (09959.HK) - Mobi Development (00947.HK) - Qingci Games (06633.HK) - Tianlun Gas (01600.HK) - Tongrentang Technology (01666.HK) - Weimob Group (02013.HK) - Zhonghui Group (00382.HK) - The ranking is in alphabetical order and does not imply any hierarchy [1]. Group 2: Evaluation Criteria - The award is based on a combination of quantitative data analysis and expert review, ensuring a comprehensive evaluation of the companies' ESG efforts [1]. - The aim of the award is to identify green enterprises and advanced companies that excel in promoting ESG principles and pursuing high-quality sustainable development [1]. Group 3: Event Overview - The event "Technology Empowerment, Capital Breakthrough" was held online on December 22, where the prestigious list of outstanding companies was announced [1]. - The "Golden Award" aims to create a valuable reference for investors by ranking listed companies and unicorns across various stock exchanges, including Hong Kong, Shanghai, Shenzhen, New York, and NASDAQ [2].

Core Viewpoint - The Chengdu Xindu District Market Supervision Administration has initiated an investigation into Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. regarding the alleged misrepresentation of a product labeled as "99% Pure Antarctic Krill Oil" [1][3]. Group 1: Investigation and Findings - A joint investigation team has been established by provincial and municipal market supervision departments to look into the allegations against the company [1]. - The Shanghai Consumer Protection Commission has identified two main fraudulent behaviors by the involved companies: knowingly misrepresenting the product's phospholipid content and misleading marketing practices [4][6]. Group 2: Company Responses - Beijing Tongrentang Health Pharmaceutical Co., Ltd. has ordered the cessation of sales of the disputed product and is conducting a thorough review of the situation [6]. - The company has also announced legal actions against the involved parties for unauthorized use of its brand name, which misled consumers [7]. Group 3: Consumer Protection Actions - The Shanghai Consumer Protection Commission has urged the company to conduct a self-examination, apologize to consumers, recall the problematic products, and provide compensation [4][6]. - Beijing Tongrentang Group has expressed deep regret over the incident and is committed to ensuring consumer rights are protected [6][7].

Core Viewpoint - The investigation into the "Antarctic Krill Oil Gel Candy" by Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. has revealed serious allegations of product misrepresentation and fraud, leading to regulatory scrutiny and potential legal consequences for the involved parties [1][6][7]. Group 1: Investigation and Regulatory Actions - The Chengdu New District Market Supervision Administration has established a joint investigation team to look into the allegations against Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. and has initiated a case against the company [1]. - The Shanghai Consumer Protection Committee has conducted tests on 15 popular Antarctic krill oil products, finding that one product from Beijing Tongrentang contained no actual krill oil, despite claims of high purity [3]. - The Shanghai Consumer Protection Committee has urged the involved companies to conduct self-examinations, apologize to consumers, recall the problematic products, and provide legal compensation [6]. Group 2: Company Responses and Accountability - Beijing Tongrentang Group has issued a public apology, expressing deep concern over the consumer rights violations and committing to a thorough investigation of the involved products [6][7]. - The company has mandated the immediate removal of the implicated products from the market and is pursuing legal action against the responsible parties for trademark infringement and misleading marketing practices [7]. - A special task force will be dispatched by Beijing Tongrentang to conduct a comprehensive review of the situation and hold accountable those responsible for the mismanagement and oversight failures [7].

【导读】同仁堂集团就南极磷虾油事件致歉：全面开展品牌清理行动 中国基金报记者 晨曦 同仁堂集团，公开致歉！ 12 月 20 日上午，北京同仁堂集团发布致歉声明。声明称，针对近日有关 " 南极磷虾油 " 的舆论关注，北京同仁堂集团高度重视、深感痛心，对因此给消费者造成的权益损害，向广 大消费者和社会各界致以最诚恳的歉意。 同仁堂集团立即开展零容忍品牌严管专项行动，已采取如下措施： 一、 派专项工作组到四川，对涉事产品开展全面深入核查，坚决一查到底。 二、 责令并监督涉事经销主体四川健康立即下架涉事产品，严格按照监管部门要求依法依规 对消费者进行赔偿。 三、 依法追究四川健康、哈博药业及相关电商平台的商标侵权等责任。对其违法使用 " 北京 同仁堂 " 字样，误导消费者判断，损害消费者合法权益的行为追究法律责任。 四、 对四川健康及其控股股东健康药业等单位在经营、管理、监督环节存在的问题开展问 责，严肃追究相关人员责任。 此外，同仁堂集团还表示，为进一步保护消费者权益，强化品牌保护责任，将开展以下工 作：全面排查品牌使用中的违法违规行为，对集团各级企业的品牌使用情况进行拉网式核 查。全面开展品牌清理行动，坚决清理 ...

Core Viewpoint - Tongrentang Technology Company utilizes the "Brilliant China" exhibition to revitalize its century-old brand, showcasing the depth of traditional Chinese medicine culture and its modern vitality [1][10]. Brand Communication Strategy - The company captures the emotional needs of modern consumers, creating a brand communication matrix that resonates deeply with both physical and emotional aspects of health [2]. - The emotional connection is emphasized through storytelling, such as the narrative around "36.5 degrees Celsius" representing both health and emotional warmth [5]. Product Focus and Health Philosophy - The company promotes its products like Beijing Tongrentang Cold Relief Granules, linking their efficacy to emotional support and everyday life experiences [5]. - The philosophy of "preventive treatment" is highlighted through products like Liuwei Dihuang Wan, which not only address health issues but also support a balanced lifestyle [7]. Brand Recognition and Industry Impact - The participation in the "Brilliant China" exhibition signifies national recognition of the company's brand strength and industry position, merging traditional wisdom with modern technology [10]. - The company's approach serves as a model for brand upgrading in the traditional Chinese medicine sector, contributing to the broader health consumption market [10]. Future Directions - The company aims to continue its commitment to traditional Chinese medicine while exploring innovative paths for development and enhancing product quality through technology [10]. - Plans include deepening the core product matrix, innovating communication strategies, and accelerating international expansion to showcase the unique charm of traditional Chinese medicine globally [10].

Core Viewpoint - The article highlights the alarming findings regarding the quality of Antarctic krill oil products, particularly focusing on a product marketed by Beijing Tongrentang, which was found to contain no phospholipids despite claims of high purity and content [4][6][9]. Group 1: Product Quality Issues - A product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" was tested and found to have a phospholipid content of 0, contradicting its advertised claims of 43% [6][9]. - The product's distributor, Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., and the manufacturer, Anhui Habao Pharmaceutical Co., Ltd., were implicated in the scandal, with the manufacturer admitting to not including the claimed Antarctic krill oil in production [12][13]. - The product was sold at approximately 60 yuan per bottle, while the production cost was only 3 to 3.7 yuan, raising questions about the pricing and quality of the product [14]. Group 2: Brand Trust and Reputation - The incident is part of a larger pattern of trust issues surrounding the Tongrentang brand, which has faced multiple controversies over product quality and misleading marketing practices [22][24]. - The article emphasizes that the trust erosion for a brand with over 350 years of history is detrimental, as each instance of compromised integrity undermines the brand's foundational values [33]. - The article calls attention to the broader implications for consumer confidence in health products, suggesting that such incidents can negatively impact overall consumption and market trust [29][30]. Group 3: Regulatory and Market Implications - The article points out the regulatory gaps and brand authorization issues that allow for such misleading products to enter the market, indicating a need for stricter oversight [32]. - The Shanghai Consumer Protection Commission is actively investigating the matter and has urged consumers to be cautious when purchasing health-related products [27]. - The article concludes that the presence of substandard products like the Antarctic krill oil not only harms consumer rights but also poses a risk to the growth of health consumption as a key driver of economic demand [28][29].

Core Points - A product labeled as "Beijing Tongrentang 99% High Purity Antarctic Krill Oil" claimed a phospholipid content of 43%, but actual tests showed it to be 0, indicating potential false advertising and consumer rights violations [2] - The distributor of the product is Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., while the manufacturer is Anhui Hab Pharmaceutical Co., Ltd. Beijing Tongrentang Health Pharmaceutical Co., Ltd. stated that the product was unauthorized and will pursue legal action against the involved companies [2] - The relationship between the companies is complex, with Beijing Tongrentang Health Pharmaceutical Co., Ltd. holding a 51% stake in Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., raising questions about accountability and the potential damage to the Tongrentang brand [2] Company and Industry Summary - The incident highlights issues of brand integrity and consumer trust within the health product industry, particularly for established brands like Beijing Tongrentang [2] - The Shanghai Consumer Protection Committee's involvement indicates regulatory scrutiny and the potential for broader implications for the industry regarding product labeling and consumer rights [2] - The situation raises concerns about the responsibilities of parent companies in overseeing the actions of their subsidiaries, especially in the context of product quality and marketing claims [2]